Lowest Price Guaranteed From USD 1,899
Published
October 2014
Pages
226
View Count
10591
Example Insights
Report Description
With increasing awareness about occupational safety and growing concern on the prevention of needlestick injury, safety injection devices have gained increased attention from the manufacturers and healthcare professionals worldwide. The accelerated emergence of regulatory controls over the past few years have further ensured that manufacturers come up with modifications in the product design and integrated safety controls to meet the requirements.
Safety injection devices, which include safety syringes and safety needles, are designed to enhance safety of the drug administration process and eliminate needlestick injuries - a major cause of blood-borne infections. The current growth in the market for a variety of safety injection devices is primarily underpinned by the evolving needs of the patients and the requirement for better and safer syringe systems.
These devices have several advantages over traditional drug delivery systems. Most importantly, the addition of safety feature provides optimal protection to the healthcare practitioners and patients, reducing the risk of accidental needlestick injuries. Specifically, in case of a retractable syringe, the needle is locked into the barrel of the syringe and the entire assembly can be safely disposed of. The cost of disposal of a safety syringe is relatively much lower compared to a conventional syringe. Despite a marginally relatively higher purchase price, these devices are known to offer long term economic advantage if the consequences of a needlestick injury and associated treatment expenses are taken into consideration.
In addition to the existing established device manufacturers, the market has seen the presence of some relatively new players. These start-ups have recently introduced some important safety devices with innovative features. The need for improvement in safety mechanisms and functionality of the devices will continue to present positive growth prospects for the market in the foreseeable future.
Scope of the Report
The ‘Needlestick Safety Injection Devices Market, 2014-2024’ report provides an extensive study of the growing market of safety injection devices. This includes safety syringes, safety needles and other add-on safety tools. Due to the recent surge of regulations and the need for injection safety at healthcare settings, safety injection devices have emerged as one of the key focus areas for device manufacturers. The market is characterized by the presence of around 70 safety injection devices providing optimal protection from needlestick injuries to the patients as well as caregivers. When compared to the conventional drug delivery systems, these devices offer several other advantages including convenient disposal and long-term economic advantage. The focus of this report is primarily to understand the governing trends and the likely future evolution of these devices over the next decade.
The report covers various aspects such as regulatory guidelines, market developments, recent partnerships and our opinion on the likely drivers which will influence the industry’s evolution. In addition, we have provided a holistic view of the market landscape including detailed profiles of leading devices, key features and their comparative position vis-à-vis other devices. The future growth in the market will primarily be driven by the rapidly expanding injectable drugs market and regulatory legislations encouraging the use of safety injection devices. Innovation in design and advanced safety mechanisms will continue to present development prospects in the years ahead.
Despite some of these key benefits and a promising future, the study also highlights considerable challenges associated with the use and implementation of these devices. The modification in design and incorporation of safety features present operational challenges to the administrators. Furthermore, cost is yet another factor that can significantly restrain the market in the short term. However, as the sales volume gains momentum, prices are expected to come down which will further drive the uptake of such devices.
The base year for the report is 2013. The study provides short-midterm and long term market forecasts for the period 2014 - 2019 and 2019 - 2024, respectively. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered from both secondary and primary research.
Contents
Chapter 2 provides an executive summary of the insights captured in our research. The summary offers a high level view on the likely evolution of safety injection devices.
Chapter 3 provides a general introduction on the safety injection devices. We have also covered, in detail, the concept behind needlestick injuries, regulatory landscape, categorization of safety devices and associated challenges with the use of such devices.
Chapter 4 identifies the various safety devices available in the market; these include safety syringes, safety needles and add-on safety tools. The chapter also provides details on some alternative needle based safety devices including safety blood collection/infusion sets, auto-injectors, blunt fill needles and needleless injection and connector systems.
Chapter 5 includes analysis of various safety syringes that are available in the market, with detailed description on retractable and non-retractable syringes. An in-depth review, including distribution by type of safety feature, mode of activation, and analysis by price, has been covered in this chapter. The chapter also includes a comprehensive section on product profiles wherein all the safety syringes identified have been explained, with information on the product development history, usage/mechanism and key advantages.
Chapter 6 focuses specifically on safety needles that are currently available in the market. It provides a comprehensive review of the key parameters related to these devices including the mode of activation and price. In addition, it includes profiles of all the safety needles we were able to identify in the research.
Chapter 7 analyzes the market developments with respect to safety injection devices. It discusses the drugs and therapeutic products that are marketed along with the safety devices. It also contains information about the partnerships in this field that have taken place in the past few years.
Chapter 8 presents a detailed ten year forecast for the safety syringes market. Due to the uncertainty surrounding some of the key assumptions, we have presented three different growth tracks outlined as conservative, base and optimistic scenarios.
Chapter 9 includes profiles of key companies active in the safety injection devices market. Each company profile includes information such as financial performance, product portfolio, recent developments and future growth outlook.
Chapter 10 provides information on the regional/other manufacturers which have been actively involved in the market. The chapter also contains a section on the comparison of product portfolio for these companies.
Chapter 11 provides the SWOT analysis of the safety injection devices market giving strategic insights to the major factors that are likely to drive future growth while also highlighting the weakness and threats that can negatively impact the industry’s evolution.
Chapter 12 is a collection of transcripts of interviews conducted during the course of this study.
Chapter 13 summarizes the overall report. In this chapter, we provide a recap of the key takeaways and our independent opinion based on the research and analysis described in previous chapters.
Chapter 14 is an appendix which provides tabulated data and numbers for all the figures provided in the report.
Chapter 15 is an appendix which provides a list of companies and organizations mentioned in the report.
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. Needlestick Injuries
3.2.1. Incidence and Cost Burden
3.3. Needle Safety Devices: Definition
3.4. OSHA: Categorization of Needle Safety Devices
3.5. Needle Safety Devices: Desirable Characteristics
3.6. Needle Safety Devices: Challenges
3.7. Regulatory Landscape
3.7.1. Federal Regulations
3.7.1.1. Needlestick Safety and Prevention Act
3.7.1.2. Regional Compliance
3.7.2. State Regulations
3.7.3. International Regulations
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. Safety Injection Devices
4.2.1. Safety Injection Devices: Distribution by Type
4.2.2. Safety Injection Devices: Manufacturer’s Landscape
4.3. Cost Comparison
4.4. Other Devices
4.4.1. Safety Blood Collection / Infusion Sets
4.4.2. Autoinjectors
4.4.2.1. Pen Injectors vs. Autoinjectors
4.4.2.2. Safety Options in Self Injectors
4.4.3. Blunt Fill Needles
4.4.4. Needle Free Injection Technology
5. SAFETY SYRINGES
5.1. Chapter Overview
5.2. Components of a Safety Syringe
5.3. Types of Safety Syringes
5.4. Retractable Syringes
5.4.1. List of Retractable Syringes
5.5. Non Retractable/ Needle Shield Syringes
5.5.1. List of Non-Retractable Safety Syringes
5.6. Analysis by Price
5.7. Mapping the Competitive Landscape
5.8. Product Profiles
5.8.1. Section Overview
5.8.2. RevVac Safety Syringe
5.8.2.1. Introduction
5.8.2.2. Product Description
5.8.2.3. Development History
5.8.2.4. Usage/Mechanism
5.8.2.5. Advantages
5.8.3. Unifill Syringe
5.8.3.1. Introduction
5.8.3.2. Product Description
5.8.3.3. Development History
5.8.3.4. Usage/Mechanism
5.8.3.5. Advantages
5.8.4. The FreeVac Safety Syringe
5.8.4.1. Introduction
5.8.4.2. Product Description
5.8.4.3. Development History
5.8.4.4. Usage/Mechanism
5.8.4.5. Advantages
5.8.5. VanishPoint Syringe
5.8.5.1. Introduction
5.8.5.2. Product Description
5.8.5.3. Development History
5.8.5.4. Usage/Mechanism
5.8.5.5. Advantages
5.8.6. Mysafety Syringe
5.8.6.1. Introduction
5.8.6.2. Product Description
5.8.6.3. Development History
5.8.6.4. Mechanism/Usage
5.8.6.5. Advantages
5.8.7. MedPro Passive Safety Syringe
5.8.7.1. Introduction
5.8.7.2. Product Description
5.8.7.3. Development History
5.8.7.4. Usage/Mechanism
5.8.7.5. Advantages
5.8.8. SafePro Plus Safety Syringe
5.8.8.1. Introduction
5.8.8.2. Product Description
5.8.8.3. Development History
5.8.8.4. Usage/Mechanism
5.8.8.5. Advantages
5.8.9. Syringex Safety Syringe
5.8.9.1. Introduction
5.8.9.2. Product Description
5.8.9.3. Development History
5.8.9.4. Usage/Mechanism
5.8.9.5. Advantages
5.8.10. UNIQSAFE Safety Syringe
5.8.10.1. Introduction
5.8.10.2. Product Description
5.8.10.3. Development History
5.8.10.4. Usage/Mechanism
5.8.10.5. Advantages
5.8.11. BakSnap Retractable Safety Syringe
5.8.11.1. Introduction
5.8.11.2. Product Description
5.8.11.3. Usage/Mechanism
5.8.11.4. Advantages
5.8.12. BD Safety-Lok Syringe
5.8.12.1. Introduction
5.8.12.2. Product Description
5.8.12.3. Development History
5.8.12.4. Usage/Mechanism
5.8.12.5. Advantages
5.9. Other Safety Syringes
5.9.1. SureSafe Retractable Syringe
5.9.2. Medicina Safety Syringes
5.9.3. Medigard Safety Syringes
5.9.4. Elite Safety Syringe
5.9.5. The Protectus Safety Syringe
5.9.6. Q Stat Safety Syringe
5.9.7. SecureTouch Syringe
5.9.8. Ultra Safety Plus XL Safety Syringe
5.9.9. Needle-Pro Edge Safety Device
5.9.10. SOL-CARE Luer Lock Safety Syringe
5.9.11. SafeSnap Safety Syringe
5.9.12. BD Integra Syringe with Retracting PrecisionGlide Needle
5.9.13. Star ID device
5.9.14. SurGuard3 Hypodermic Syringe with Safety Needle
5.9.15. Wenzhou Safety Syringe
5.9.16. Magellan Hypodermic Safety Needle & Syringe Combinations
5.9.17. Monoject Safety Syringes
5.9.18. ClickZip Needle Retractable Safety Syringe
5.9.19. RauSafe
5.9.20. Fulject Safety Syringe
5.9.21. Epiphany Safe Shot Safety Syringe
5.9.22. BD Safety Glide Syringe for Insulin, TB and Allergy
6. SAFETY NEEDLES
6.1. Chapter Overview
6.2. Types of Safety Needles
6.3. Distribution by Mode of Activation
6.4. List of Safety Needles
6.5. Analysis by Price
6.6. Product Profiles
6.6.1. Section Overview
6.6.2. K-Pack Surshield Needle
6.6.2.1. Introduction
6.6.2.2. Product Description
6.6.2.3. Mechanism/Usage
6.6.2.4. Advantages
6.6.2.5. Current Status
6.6.3. NovaGuard
6.6.3.1. Introduction
6.6.3.2. Product Description
6.6.3.3. Mechanism/Usage
6.6.3.4. Advantages
6.6.3.5. Current Status
6.6.4. SurGuard3 Hypodermic Syringe with Safety Needle
6.6.4.1. Introduction
6.6.4.2. Product Description
6.6.4.3. Mechanism/Usage
6.6.4.4. Advantages
6.6.5. BD AutoShield Duo Pen Needle
6.6.5.1. Introduction
6.6.5.2. Product Description
6.6.5.3. Mechanism/Usage
6.6.5.4. Advantages
6.6.5.5. Current Status
6.6.6. BD SafetyGlide Shielding Hypodermic Needle
6.6.6.1. Introduction
6.6.6.2. Product Description
6.6.6.3. Mechanism/Usage
6.6.6.4. Advantages
6.6.6.5. Current Status
6.7. Other Safety Needles
6.7.1. BD Eclipse Needle
6.7.2. Wenzhou Safety Insulin Pen Needle
6.7.3. The Click In Safety Shield System
6.7.4. Magellan Hypodermic Safety Needles
6.7.5. Novo Nordisk NovoFine Autocover
6.7.6. Safety Tip needles
6.7.7. Needle-Trap device
6.7.8. Med-Lok Safety Needle
6.7.9. Autosafe-Reflex Safety Needle
7. MARKET DEVELOPMENTS
7.1. Marketed Drugs in/with Safety Devices
7.2. Deals and Partnerships
8. MARKET SIZE AND FORECAST
8.1. Chapter Overview
8.2. Forecast Methodology
8.3. Overall Safety Syringes Market, 2014-2024 (Value and Volume)
8.4. Retractable Safety Syringes Market, 2014- 2024 (Value and Volume)
8.5. Non-retractable Safety Syringes Market, 2014- 2024 (Value and Volume)
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Unilife Corporation
9.2.1. Overview and Background
9.2.2. Financial Performance
9.2.3. Product Portfolio
9.2.3.1. Unifill Platform of Prefilled Syringes
9.2.3.2. EZMix Platform of Dual-Chamber Syringes (Drug Reconstitution Delivery Systems)
9.2.3.3. Auto-Injector Platform
9.2.3.4. Wearable Injector Platform
9.2.3.5. Ocular Delivery Systems
9.2.3.6. Novel Delivery Systems
9.2.4. Recent Developments
9.2.4.1. Partnership with Novartis
9.2.4.2. Partnership with A Global Pharmaceutical Company (undisclosed)
9.2.4.3. Partnership with Medimmune
9.2.4.4. Partnership with Hikma
9.2.4.5. Partnership with Sanofi
9.2.4.6. Partnership with Biodel
9.2.5. Future Outlook
9.3. West Pharmaceuticals
9.3.1. Overview and Background
9.3.2. Financial Performance
9.3.3. Product Portfolio
9.3.3.1. Marketed Products
9.3.3.2. Pipeline Products
9.3.4. Recent Developments
9.3.4.1. Advancing The Growth Of CZ Syringes
9.3.4.2. Looking to Grow in Pharmerging Markets (Brazil, China, India)
9.3.4.3. Agreement with Janssen Biotech
9.3.5. Future Outlook
9.4. BD Medical, A Segment Of Becton, Dickinson and Company
9.4.1. Overview and Background
9.4.2. Financial Performance
9.4.3. Product Portfolio
9.4.4. Recent Developments
9.4.4.1. Agreement with Biodel
9.4.4.2. Collaboration with World Health Organization (WHO)
9.4.4.3. Launch of BD Sterifill Advance
9.4.4.4. Entering the Generic Business
9.4.4.5. Acquisition of Cato Software Solutions
9.4.4.6. Acquisition of Safety Syringes
9.4.5. Future Outlook
9.5. Smiths Medical
9.5.1. Overview and Background
9.5.2. Financial Performance
9.5.3. Product Portfolio
9.5.4. Recent Developments
9.5.5. Future Outlook
9.6. Catalent
9.6.1. Financial Performance
9.6.2. Product Portfolio
9.6.3. Recent Developments
9.6.4. Future Outlook
9.7. Terumo Medical Corporation
9.7.1. Financial Performance
9.7.2. Product Portfolio
9.7.3. Recent Developments
9.7.3.1. Agreement with CareFusion
9.7.3.2. Growing Focus on Safety Devices
9.7.3.3. Launch of SurGuard3
9.7.4. Future Outlook
9.8. Covidien
9.8.1. Financial Performance
9.8.2. Product Portfolio
9.8.3. Future Outlook
10. REGIONAL/OTHER NEEDLE BASED SAFETY DEVICES MANUFACTURERS
10.1. Chapter Overview
10.2. Regional Safety Injection Device Manufacturers: Comparative Landscape
10.3. Revolutions Medical Corporation
10.4. Beipu
10.5. Formosa Medical Devices
10.6. UNIQSAFE Biomeditech Company
10.7. Taisei Kako
11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
12. INTERVIEW TRANSCRIPTS
13. CONCLUSION
13.1. Transition From Conventional Devices To Safety Injection Devices
13.2. Technological Advancements Have Ensured That These Devices Continue to Gain Traction From Healthcare Practitioners And Patients Alike
13.3. A Multi-Billion Dollar Rapidly Growing Market
13.4. Concluding Remarks
14. APPENDIX 1: TABULATED DATA
15. APPENDIX 2: LIST OF COMPANIES
Figure 3.1 Occurrence of Needlestick Injuries
Figure 4.1 Safety Injection Devices: Distribution by Type
Figure 4.2 Safety Injection Devices: Distribution by Companies
Figure 4.3 Safety Injection Devices: Leading Companies
Figure 5.1 Types of Safety Syringes
Figure 5.2 Safety Syringes: Distribution by Type
Figure 5.3 Safety Syringes: Distribution by Mode of Activation
Figure 5.4 Safety Syringes: Analysis by Price
Figure 5.5 Safety Syringes: Product Competitiveness Analysis
Figure 5.6 Safety Syringes: Product Profiling Framework
Figure 6.1 Safety Needles: Distribution by Mode of Activation
Figure 6.2 Safety Needles: Analysis by Price
Figure 6.3 Safety Needles: Product Profiling Framework
Figure 8.1 Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
Figure 8.2 Overall Safety Syringes Market, Long Term (2019 - 2024): Base Scenario (Billion Units)
Figure 8.3 Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
Figure 8.4 Overall Safety Syringes Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
Figure 8.5 Number of Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
Figure 8.6 Number of Retractable Safety Syringes, Long Term (2019 - 2024): Base Scenario (Billion Units)
Figure 8.7 Retractable Syringes, 2014-2024: Distribution by Price Tiers
Figure 8.8 Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
Figure 8.9 Retractable Safety Syringe Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
Figure 8.10 Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
Figure 8.11 Number of Non-Retractable Safety Syringes, Long Term (2019 - 2024): Base Scenario (Billion Units)
Figure 8.12 Non-retractable Syringes, 2014-2024: Distribution by Price Tiers
Figure 8.13 Non-Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
Figure 8.14 Non-Retractable Safety Syringe Market, Long Term (2019 -2024): Base Scenario (USD Billion)
Figure 9.1 Revenues, Unilife Corporation, FY 2011 - FY 2013 (USD ‘000)
Figure 9.2 West Pharmaceutical Services: Revenues, 2009-2013 (USD Million)
Figure 9.3 West Pharmaceutical Services: Revenues by Business Segments, 2011-2013 (USD Million)
Figure 9.4 Becton Dickinson: Revenues, 2009-2013 (USD Million)
Figure 9.5 Becton Dickinson: Revenues by Business Divisions, 2013 (USD Billion, %)
Figure 9.6 BD Medical: Revenues by Business Divisions, 2013 (USD Billion, %)
Figure 9.7 Smiths Group: Revenues, 2009-2013 (GBP Million)
Figure 9.8 Smiths Group: Revenues by Business Divisions, FY 2013 (GBP Million)
Figure 9.9 Smiths Medical: Revenues by Business Segments, FY 2012 - FY 2013 (GBP Million)
Figure 9.10 Catalent: Revenues, 2009-2013 (USD Million)
Figure 9.11 Catalent: Revenues by Business Segments, FY 2013 (USD Million)
Figure 9.12 Terumo Corporation: Revenues, FY09-FY 13 (JPY Billion)
Figure 9.13 Terumo Corporation: Revenues by Business Segments, FY 2013 (JPY Billion)
Figure 9.14 Covidien: Revenues, 2009-2013 (USD Million)
Figure 9.15 Covidien: Revenues by Business Segments, 2012-2013 (USD Million)
Figure 9.16 Covidien Medical Supplies: Revenues by Product Segments, 2013 (USD Million)
Figure 13.1 Safety Syringes Market (USD Billion): Comparative Scenarios, 2014, 2019 and 2024
Table 3.1 Blood-borne Infections: Frequency of Occurrence
Table 3.2 Needle Safety: State Legislations
Table 4.1 List of Safety Injection Devices
Table 4.2 Cost Comparison: Safety Syringe and Conventional Syringe
Table 4.3 List of Safety Blood Collection / Infusion Sets
Table 4.4 Auto-injector/Pen-injector Systems Approved in 2013-2014
Table 4.5 Auto-injector/Pen-injector Systems (Using Prefilled Syringes) Available in the Market
Table 4.6 List of Blunt Fill Needles
Table 4.7 List of Needleless Injection Systems
Table 5.1 List of Retractable Safety Syringes
Table 5.2 Non Retractable Syringes: Disadvantages
Table 5.3 List of Non-Retractable Safety Syringes
Table 5.4 Safety Syringes: Purchase Price
Table 5.5 VanishPoint Syringe: Needle Size Description
Table 5.6 MySafety Syringe: Needle Size Description
Table 5.7 MySafety Syringe: Approval History
Table 5.8 Difference between SafePro Series and SafePro Plus Series
Table 5.9 SafePro Plus Safety Syringe: Needle Size Description
Table 5.10 UNIQSAFE Safety Syringe: Needle Size Description
Table 5.11 BD Safety-Lok Syringe: Needle Size Description
Table 6.1 List of Active Safety Needles
Table 6.2 List of Passive Safety Needles
Table 6.3 Safety Needles: Purchase Price
Table 6.4 K-Pack Surshield: Key Specifications
Table 6.5 Difference betweenSurGuard3 and SurGuard2 Safety Needle
Table 6.6 SurGuard3 Safety Needle: Needle Size Description
Table 6.7 BD SafetyGlide Shielding Hypodermic Needle: Key Specifications
Table 6.8 BD SafetyGlide Hypodermic Shielding Needle: Needle Size Description
Table 7.1 List of Marketed Drugs in/with Safety Devices
Table 7.2 Safety Injection Devices: Deals and Partnerships
Table 8.1 Retractable Syringes: Price Points
Table 8.2 Non-retractable Syringes: Price Points
Table 9.1 Becton Dickinson: List of Safety Injection Devices
Table 9.2 Terumo: Financial Targets of Mid-term Plan
Table 10.1 Regional Safety Injection Device Manufacturers: Comparison of Product Portfolio
Table 11.1 SWOT Analysis
Table 11.2 Recall of Autoinjectors
Table 11.3 Prefilled Syringe Recalls, 2003-2014
Table 13.1 Safety Syringes: Analysis by Volume
Table 14.1 Safety Injection Devices: Distribution by Type
Table 14.2 Safety Injection Devices: Distribution by Companies
Table 14.3 Safety Injection Devices: Leading Companies
Table 14.4 Safety Syringes: Distribution by Type
Table 14.5 Safety Syringes: Distribution by Mode of Activation
Table 14.6 Safety Needles: Distribution by Mode of Activation
Table 14.7 Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Base Scenario (Billion Units)
Table 14.8 Overall Safety Syringes Market, Long Term (2019 – 2024): Base Scenario (Billion Units)
Table 14.9 Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Conservative Scenario (Billion Units)
Table 14.10 Overall Safety Syringes Market, Long Term (2019 – 2024): Conservative Scenario (Billion Units)
Table 14.11 Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Optimistic Scenario (Billion Units)
Table 14.12 Overall Safety Syringes Market, Long Term (2019 – 2024): Optimistic Scenario (Billion Units)
Table 14.13 Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Base Scenario (USD Billion)
Table 14.14 Overall Safety Syringes Market, Long Term (2019 – 2024): Base Scenario (USD Billion)
Table 14.15 Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Conservative Scenario (USD Billion)
Table 14.16 Overall Safety Syringes Market, Long Term (2019 – 2024): Conservative Scenario (USD Billion)
Table 14.17 Overall Safety Syringes Market, Short-Mid Term (2014 – 2019): Optimistic Scenario (USD Billion)
Table 14.18 Overall Safety Syringes Market, Long Term (2019 – 2024): Optimistic Scenario (USD Billion)
Table 14.19 Number of Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Base Scenario (Billion Units)
Table 14.20 Number of Retractable Safety Syringes, Long Term (2019 – 2024): Base Scenario (Billion Units)
Table 14.21 Number of Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Conservative Scenario (Billion Units)
Table 14.22 Number of Retractable Safety Syringes, Long Term (2019 – 2024): Conservative Scenario (Billion Units)
Table 14.23 Number of Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Optimistic Scenario (Billion Units)
Table 14.24 Number of Retractable Safety Syringes, Long Term (2019 – 2024): Optimistic Scenario (Billion Units)
Table 14.25 Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Base Scenario (USD Billion)
Table 14.26 Retractable Safety Syringe Market, Long Term (2019 – 2024): Base Scenario (USD Billion)
Table 14.27 Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Conservative Scenario (USD Billion)
Table 14.28 Retractable Safety Syringe Market, Long Term (2019 – 2024): Conservative Scenario (USD Billion)
Table 14.29 Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Optimistic Scenario (USD Billion)
Table 14.30 Retractable Safety Syringe Market, Long Term (2019 – 2024): Optimistic Scenario (USD Billion)
Table 14.31 Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Base Scenario (Billion Units)
Table 14.32 Number of Non-Retractable Safety Syringes, Long Term (2019 – 2024): Base Scenario (Billion Units)
Table 14.33 Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Conservative Scenario (Billion Units)
Table 14.34 Number of Non-Retractable Safety Syringes, Long Term (2019 – 2024): Conservative Scenario (Billion Units)
Table 14.35 Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 – 2019): Optimistic Scenario (Billion Units)
Table 14.36 Number of Non-Retractable Safety Syringes, Long Term (2019 – 2024): Optimistic Scenario (Billion Units)
Table 14.37 Non-Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Base Scenario (USD Billion)
Table 14.38 Non-Retractable Safety Syringe Market, Long Term (2019 – 2024): Base Scenario (USD Billion)
Table 14.39 Non-Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Conservative Scenario (USD Billion)
Table 14.40 Non-Retractable Safety Syringe Market, Long Term (2019 – 2024): Conservative Scenario (USD Billion)
Table 14.41 Non-Retractable Safety Syringe Market, Short-Mid Term (2014 – 2019): Optimistic Scenario (USD Billion)
Table 14.42 Non-Retractable Safety Syringe Market, Long Term (2019 – 2024): Optimistic Scenario (USD Billion)
Table 14.43 Revenues, Unilife Corporation, FY 2011 - FY 2013 (USD ‘000)
Table 14.44 West Pharmaceutical Services: Revenues, 2009-2013 (USD Million)
Table 14.45 West Pharmaceutical Services: Revenues by Business Segments, 2011-2013 (USD Million)
Table 14.46 Becton Dickinson: Revenues, 2009-2013 (USD Million)
Table 14.47 Becton Dickinson: Revenues by Business Divisions, 2013 (USD Billion, %)
Table 14.48 BD Medical: Revenues by Business Segments, 2013 (USD Billion, %)
Table 14.49 Smiths Group: Revenues, 2009-2013 (GBP Million)
Table 14.50 Smiths Group: Revenues by Business Divisions, FY 2013 (GBP Million)
Table 14.51 Smiths Medical: Revenues by Business Segments, FY 2012 - FY 2013 (GBP Million)
Table 14.52 Catalent: Revenues, 2009-2013 (USD Million)
Table 14.53 Catalent: Revenues by Business Divisions, FY 2013 (USD Million)
Table 14.54 Terumo Corporation: Revenues, FY09-FY 13 (JPY Billion)
Table 14.55 Terumo Corporation: Revenues by Business Segments, FY 2013 (JPY Billion)
Table 14.56 Covidien: Revenues, 2009-2013 (USD Million)
Table 14.57 Covidien: Revenues by Business Segments, 2012-2013 (USD Million)
Table 14.58 Covidien Medical Supplies: Revenues by Product Segments, 2013 (USD Million)
Table 14.59 Safety Syringes Market (USD Billion) Forecast: 2014, 2019 and 2024
The following companies have been mentioned in this report.
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
SUBSCRIBE TO INDUSTRY UPDATES